Pablo Sarobe

Instituto de Salud Carlos III — Spain

Immunology and Microbiology · Life Sciences

41h-index7.4kcitations214works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(104), Cancer Immunotherapy and Biomarkers(54), Hepatitis C virus research(41), Immune Cell Function and Interaction(35), Monoclonal and Polyclonal Antibodies Research(27)

Publications214 total

Epigenetic mechanisms in HCC immune landscape: Therapeutic implications
Seminars in Immunology·2025· 3 citedOpen Access
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma
2025Open Access
SAT-102 The role of Activating Factor 4 (ATF4) in the immunosuppressive phenotype of beta-catenin mutant hepatocellular carcinoma
Journal of Hepatology·2025
FRI-123 The dose of radiation absorbed by the tumorand the non-tumoral compartments does not impact peripheral immune markers after SIRT
Journal of Hepatology·2025
Supplementary Figure 9 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 14 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 3 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 15 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 13 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 12 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 1 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 4 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 10 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 7 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 6 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 5 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 11 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Data from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Table 1 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
Supplementary Figure 8 from The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response
2025Open Access
page 1 of 11Next →

Frequent Co-authors

Juan José Lasarte(39), Jesús Prìeto(29), Francisco Borrás‐Cuesta(28), Noëlia Casares(15), José Ignacio Riezu‐Boj(14), Diana Llópiz(13), Marta Ruiz(12), Laura Arribillaga(9), Javier Dotor(9), Sandra Hervás‐Stubbs(8), Bruno Sangro(7), Teresa Lozano(7), Ignacio Melero(6), Marta Gorraiz(5), Esther Larrea(4), Lorea Villanueva(4), Leyre Silva(4), Eduardo Huarte(4), Maika Durántez(4), Mercedes Iñarrairaegui(3)